Kempharm Stock Shares Owned By Insiders
| KMPHDelisted Stock | USD 5.81 0.02 0.34% |
KemPharm fundamentals help investors to digest information that contributes to KemPharm's financial success or failures. It also enables traders to predict the movement of KemPharm Stock. The fundamental analysis module provides a way to measure KemPharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to KemPharm stock.
KemPharm |
KemPharm Company Shares Owned By Insiders Analysis
KemPharm's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current KemPharm Shares Owned By Insiders | 10.29 % |
Most of KemPharm's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KemPharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 10.29% of KemPharm are shares owned by insiders. This is 32.21% lower than that of the Pharmaceuticals sector and 27.43% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 1.98% lower than that of the firm.
KemPharm Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses KemPharm's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of KemPharm could also be used in its relative valuation, which is a method of valuing KemPharm by comparing valuation metrics of similar companies.KemPharm is currently under evaluation in shares owned by insiders category among related companies.
KemPharm Fundamentals
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0897 | |||
| Operating Margin | (1.72) % | |||
| Current Valuation | 97.06 M | |||
| Shares Outstanding | 34.5 M | |||
| Shares Owned By Insiders | 10.29 % | |||
| Shares Owned By Institutions | 17.68 % | |||
| Number Of Shares Shorted | 1.37 M | |||
| Price To Earning | 17.87 X | |||
| Price To Book | 1.69 X | |||
| Price To Sales | 14.16 X | |||
| Revenue | 28.65 M | |||
| Gross Profit | 26.59 M | |||
| EBITDA | (8.29 M) | |||
| Net Income | (8.55 M) | |||
| Cash And Equivalents | 80.98 M | |||
| Cash Per Share | 2.35 X | |||
| Total Debt | 16.16 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 12.21 X | |||
| Book Value Per Share | 2.72 X | |||
| Cash Flow From Operations | 10.44 M | |||
| Short Ratio | 5.87 X | |||
| Earnings Per Share | (0.91) X | |||
| Target Price | 22.33 | |||
| Number Of Employees | 24 | |||
| Beta | 2.16 | |||
| Market Capitalization | 200.65 M | |||
| Total Asset | 132.94 M | |||
| Retained Earnings | (252.18 M) | |||
| Working Capital | 45.74 M | |||
| Current Asset | 54.08 M | |||
| Current Liabilities | 8.34 M | |||
| Z Score | 5.8 | |||
| Net Asset | 132.94 M |
About KemPharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze KemPharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KemPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KemPharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards KemPharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, KemPharm's short interest history, or implied volatility extrapolated from KemPharm options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in KemPharm Stock
If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |